Forbion Capital Fund III Cooperatief U.A. - 10%+ Owner at enGene Therapeutics Inc.

Issuer-level insider activity

Role
10%+ Owner
Issuer ticker
ENGN, ENGNW on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Forbion Capital Fund III Cooperatief U.A. since 13 Aug 2025

Reported holdings for Forbion Capital Fund III Cooperatief U.A. in enGene Therapeutics Inc.

Form 4 holding 10%+ Owner

enGene Holdings Inc.

Security class
Class A common shares
Shares / value
2,894,735
Estimated value
Report date
31 Oct 2023
Price
Ownership
Direct

Transaction history for Forbion Capital Fund III Cooperatief U.A. in enGene Therapeutics Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .